Suono Bio Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $500K

  • Investors
  • 13

Suono Bio General Information

Description

Developer of therapeutic products designed for the treatment of inflammatory-mediated diseases. The company's platform allows ultra-rapid delivery of therapies and macromolecules across tissues including biologics and nucleic acids that are delivered directly into the gastrointestinal tissues with small molecules, proteins, vaccines, and nucleic acids, enabling patients to recover from gastrointestinal diseases.

Contact Information

Website
www.suonobio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Therapeutic Devices
Primary Office
  • 200 Foxborough Boulevard
  • Suite 100
  • Foxborough, MA 02035
  • United States

Suono Bio Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Suono Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 28-Aug-2023 $500K 000.00 Completed Clinical Trials - General
6. Later Stage VC (Series A) 07-Jul-2021 000.00 000.00 0000 Completed Pre-Clinical Trials
5. Grant 01-Jan-2019 00000 00.00 Completed Pre-Clinical Trials
4. Early Stage VC (Series A) 19-Sep-2017 00.00 00.00 000 Completed Pre-Clinical Trials
3. Accelerator/Incubator 13-Oct-2016 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2016 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2015 Completed Startup
To view Suono Bio’s complete valuation and funding history, request access »

Suono Bio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A NV 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Suono Bio’s complete cap table history, request access »

Suono Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic products designed for the treatment of inflammatory-mediated diseases. The company's platform a
Drug Delivery
Foxborough, MA
13 As of 2023
000.00
0000000000 0 000.00

000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

00 000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volup
0000 000000000
Aurora, CO
0 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Suono Bio Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Celsius (Biotechnology) Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
00 000000000000 Venture Capital-Backed Aurora, CO 0 000.00 00000000000 000.00
00000 00000 000000 Private Equity-Backed Geneva, Switzerland 000 00000 00000000000 00000
0000000 Venture Capital-Backed Emeryville, CA 000 00000 00000000000 00000
00000 000000000000 Venture Capital-Backed Boston, MA 00 00000 00000000000 00000
You’re viewing 5 of 9 competitors. Get the full list »

Suono Bio Patents

  • 7

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Suono Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4210586-A1 Ultrasound flexural waveguide Pending 14-Sep-2020 00000000
EP-3863502-A1 Tethered ultrasound devices and uses thereof Pending 11-Oct-2018 00000000
EP-3863502-A4 Tethered ultrasound devices and uses thereof Pending 11-Oct-2018 00000000000 0
US-20210316124-A1 Tethered ultrasound devices and uses thereof Pending 11-Oct-2018 00000000
EP-3823722-A1 Devices and methods for ultrasonic delivery of an agent within an oral cavity Pending 20-Jul-2018 A61M37/0092
To view Suono Bio’s complete patent history, request access »

Suono Bio Executive Team (7)

Name Title Board Seat Contact Info
Scott Kellogg Chief Executive Officer & Board Member
Carl Schoellhammer Ph.D Co-Founder, Chief Technology Officer, President & Board Member
Albert Farinha Chief Operating Officer
Giovanni Traverso Ph.D Co-Founder & Board Member
Amy Schulman JD Co-Founder & Executive Chairman
You’re viewing 5 of 7 executive team members. Get the full list »

Suono Bio Board Members (8)

Name Representing Role Since
Amy Schulman JD Self Co-Founder & Executive Chairman 000 0000
Carl Schoellhammer Ph.D Suono Bio Co-Founder, Chief Technology Officer, President & Board Member 000 0000
Frederick Shane Suono Bio Board Member 000 0000
Giovanni Traverso Ph.D Suono Bio Co-Founder & Board Member 000 0000
Robert Langer Ph.D Self Co-Founder & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Suono Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Suono Bio Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Axil Capital Partners Venture Capital Minority 000 0000 000000 0
Gutbrain Ventures Venture Capital Minority 000 0000 000000 0
Mizuho Securities Investment Bank Minority 000 0000 000000 0
PBJ Capital Venture Capital Minority 000 0000 000000 0
Taiwania Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial